Schedule
of other investments
| | |
2024 | | |
2023 | |
| | |
USD | | |
USD | |
| | |
| | |
| |
| Unquoted shares - at cost | |
| | | |
| | |
| As at 1 April/31 March | |
| 28,768 | | |
| 28,768 | |
| Other investments at cost | |
| 28,768 | | |
| 28,768 | |
| Disposal during year | |
| (26,046 | ) | |
| - | |
| | |
| | | |
| | |
| As at 31 March | |
| 2,722 | | |
| 28,768 | |
| Other investments at cost | |
| 2,722 | | |
| 28,768 | |
| | |
| | | |
| | |
| Less: Accumulated impairment loss | |
| | | |
| | |
| As at 1 April | |
| (28,748 | ) | |
| (28,405 | ) |
| Other investments, accumulated impairment loss | |
| (28,748 | ) | |
| (28,405 | ) |
| Addition during the financial year | |
| - | | |
| (343 | ) |
| Reversal of accumulated impairment loss | |
| 26,046 | | |
| - | |
| | |
| | | |
| | |
| As at 31 March | |
| (2,702 | ) | |
| (28,748 | ) |
| Other investments, accumulated impairment loss | |
| (2,702 | ) | |
| (28,748 | ) |
| | |
| | | |
| | |
| Exchange differences | |
| (20 | ) | |
| (20 | ) |
| | |
| | | |
| | |
| Other investments | |
| - | | |
| - | |
As
of 31 March 2023, the Group had carried out an assessment on fair value of these balances and the corresponding fair value loss of USD343
has been taken up in the profit or loss. There
is no fair value loss as of 31 March 2024.
|